1. Academic Validation
  2. Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity

Synthesis and evaluation of novel ether lipid nucleoside conjugates for anti-HIV-1 activity

  • J Med Chem. 1991 Apr;34(4):1408-14. doi: 10.1021/jm00108a025.
C Piantadosi 1 C J Marasco Jr S L Morris-Natschke K L Meyer F Gumus J R Surles K S Ishaq L S Kucera N Iyer C A Wallen
Affiliations

Affiliation

  • 1 University of North Carolina, School of Pharmacy, Division of Medicinal Chemistry and Natural Products, Chapel Hill 27599.
Abstract

Combinations of an amidoalkylphosphocholine, 8, and AZT have been found to cause an apparent synergistic action in suppressing infectious HIV-1 replication. In addition, amidoalkyl, oxyalkyl, and thioalkyl ether lipids have been chemically linked to anti-HIV-1 nucleosides (AZT and DDI) through phosphate and phosphonate linkages. These conjugates have shown promising in vitro anti-HIV-1 activity. Also, the conjugates have a 5-10-fold reduction in cell cytotoxicity compared to AZT alone. The most active compound, an amidoalkyl ether lipid-AZT conjugates, 4A, was found to have a differential selectivity of 1793 in a syncytial plaque assay. In comparison, AZT alone has a value of 1281.

Figures